Teriparatide and Risedronate in the Treatment of Patients with Severe Postmenopausal Osteoporosis: Comparative Effects on Vertebral Fractures
-
- STATUS
- Not Recruiting
Summary
The purpose of this study is to compare the safety of teriparatide and risedronate and how well they will work to help postmenopausal osteoporotic women who have osteoporotic spine fractures.
Description
The primary objective of this study is to evaluate if teriparatide 20 ?g subcutaneously once daily is superior in reducing the incidence of new vertebral fractures during 24 months of therapy, when compared with risedronate 35 mg orally once weekly, in postmenopausal women with prevalent vertebral fragility fractures.
Details
| Condition | osteoporosis |
|---|---|
| Age | 45years - 100years |
| Clinical Study Identifier | TX6831 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.